A detailed history of Alps Advisors Inc transactions in Organon & Co. stock. As of the latest transaction made, Alps Advisors Inc holds 706,795 shares of OGN stock, worth $10.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
706,795
Previous 571,926 23.58%
Holding current value
$10.6 Million
Previous $11.8 Million 14.21%
% of portfolio
0.09%
Previous 0.08%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $2.52 Million - $3.11 Million
134,869 Added 23.58%
706,795 $13.5 Million
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $1.37 Million - $1.72 Million
78,399 Added 15.89%
571,926 $11.8 Million
Q1 2024

May 14, 2024

BUY
$13.78 - $18.8 $1.03 Million - $1.4 Million
74,530 Added 17.79%
493,527 $9.28 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $12.2 Million - $19.2 Million
-1,110,589 Reduced 72.61%
418,997 $6.04 Million
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $2.72 Million - $3.9 Million
164,099 Added 12.02%
1,529,586 $26.6 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $3 Million - $3.83 Million
155,625 Added 12.86%
1,365,487 $28.4 Million
Q1 2023

May 10, 2023

BUY
$21.42 - $32.08 $3.4 Million - $5.09 Million
158,515 Added 15.08%
1,209,862 $28.5 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $22 Million - $27 Million
943,047 Added 870.77%
1,051,347 $29.4 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $2.53 Million - $3.71 Million
108,300 New
108,300 $2.53 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.82B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.